1Merlino G, Valente M, Serafini A, et al. Restless legs syndrome: diagnosis, epidemiology, classification and consequences. Neurol Sci, 2007, 28 Suppl 1 :$3746.
2Hening WA. Subjective and objective criteria in the diagnosis of the restless legs syndrome. Sleep Med, 2004,5:285-292.
3Hening WA. Current guidelines and standards of practice for restless legs syndrome. Am J Med, 2007,120 : S22-27.
4Silber MH, Girish M, Izurieta R. Pramipexole in the management of restless legs syndrome : an extended study. Sleep, 2003,26 : 819-821.
5Winkelman JW, Johnston L. Augmentation and tolerance with long-term pramipexole treatment of restless legs syndrome (RLS). Sleep Med, 2004,5:9-14.
6Waiters AS, Ondo WG, Dreykluft T, et al. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12- week, double-blind, randomized, parallel-group, placebo- controlled study. Mov Disord, 2004,19 : 1414-1423.
7Garcia-Borreguero D, Larrosa O, de la Llave Y, et al. Treatment of restless legs syndrome with gabapentin : a double-blind, cross-over study. Neurology, 2002,59 : 1573-1579.
8Happe S, Sauter C, Klosch G, et al. Gabapentin versus ropinirole in the treatment of idiopathic restless legs syndrome. Neuropsychobiology, 2003,48:82-86.
9Waiters AS, Winkelmann J, Trenkwaider C, et al. Long-term follow-up on restless legs syndrome patients treated with opioids. Mov Disord, 2001,16 : 1105-1109.
10Earley CJ. Clinical practice. Restless legs syndrome. N Engl J Med, 2003,348:2103-2109.
